Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
An amendment to this paper has been published and can be accessed via the original article.
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-12-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Online Access: | https://doi.org/10.1186/s13046-020-01780-y |
| id |
doaj-50cd8ad3d44049e8a30577f528436db7 |
|---|---|
| record_format |
Article |
| spelling |
doaj-50cd8ad3d44049e8a30577f528436db72020-12-13T12:04:14ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662020-12-013911610.1186/s13046-020-01780-yCorrection to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinomaFei Teng0Ju-Xiang Zhang1Qi-Meng Chang2Xu-Bo Wu3Wei-Guo Tang4Jian-Fa Wang5Jin-Feng Feng6Zi-Ping Zhang7Zhi-Qiu Hu8Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan UniversityShanghai Med-X Engineering Center for Medical Equipment and Technology, School of Biomedical Engineering, Shanghai Jiao Tong UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan UniversityAn amendment to this paper has been published and can be accessed via the original article.https://doi.org/10.1186/s13046-020-01780-y |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Fei Teng Ju-Xiang Zhang Qi-Meng Chang Xu-Bo Wu Wei-Guo Tang Jian-Fa Wang Jin-Feng Feng Zi-Ping Zhang Zhi-Qiu Hu |
| spellingShingle |
Fei Teng Ju-Xiang Zhang Qi-Meng Chang Xu-Bo Wu Wei-Guo Tang Jian-Fa Wang Jin-Feng Feng Zi-Ping Zhang Zhi-Qiu Hu Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma Journal of Experimental & Clinical Cancer Research |
| author_facet |
Fei Teng Ju-Xiang Zhang Qi-Meng Chang Xu-Bo Wu Wei-Guo Tang Jian-Fa Wang Jin-Feng Feng Zi-Ping Zhang Zhi-Qiu Hu |
| author_sort |
Fei Teng |
| title |
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_short |
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_full |
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_fullStr |
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_full_unstemmed |
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma |
| title_sort |
correction to: lncrna mylk-as1 facilitates tumor progression and angiogenesis by targeting mir-424-5p/e2f7 axis and activating vegfr-2 signaling pathway in hepatocellular carcinoma |
| publisher |
BMC |
| series |
Journal of Experimental & Clinical Cancer Research |
| issn |
1756-9966 |
| publishDate |
2020-12-01 |
| description |
An amendment to this paper has been published and can be accessed via the original article. |
| url |
https://doi.org/10.1186/s13046-020-01780-y |
| work_keys_str_mv |
AT feiteng correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT juxiangzhang correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT qimengchang correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT xubowu correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT weiguotang correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT jianfawang correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT jinfengfeng correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT zipingzhang correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT zhiqiuhu correctiontolncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma |
| _version_ |
1724385314887172096 |